These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 11858449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R, Theriault RL.
    J Natl Cancer Inst Monogr; 1994 Jul 01; (16):153-9. PubMed ID: 7999459
    [Abstract] [Full Text] [Related]

  • 10. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL, Connelly MT, Newton KM, Andrade SE, Wei F, Buist DS.
    J Natl Cancer Inst Monogr; 2005 Jul 01; (35):113-5. PubMed ID: 16287896
    [Abstract] [Full Text] [Related]

  • 11. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD.
    Ann N Y Acad Sci; 2005 Jun 01; 1052():57-74. PubMed ID: 16024751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL, Chao HT, Cheng MH, Wang PH.
    Maturitas; 2008 Jun 20; 60(2):92-107. PubMed ID: 18534794
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy in postmenopausal women.
    Yasui T, Uemura H, Takikawa M, Irahara M.
    J Med Invest; 2003 Aug 20; 50(3-4):136-45. PubMed ID: 13678382
    [Abstract] [Full Text] [Related]

  • 18. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR, Gambacciani M.
    Gynecol Endocrinol; 2002 Aug 20; 16(4):255-7. PubMed ID: 12396552
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evidence-based assessment of the impact of the WHI on women's health.
    Burger HG, MacLennan AH, Huang KE, Castelo-Branco C.
    Climacteric; 2012 Jun 20; 15(3):281-7. PubMed ID: 22612616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.